Marshall Wace’s Cigna CI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$40M Buy
+150,000
New +$41.5M 0.04% 439
2025
Q4
Sell
-273,900
Closed -$79M 3014
2025
Q3
$79M Buy
273,900
+176,300
+181% +$52.2M 0.08% 217
2025
Q2
$32.3M Buy
+97,600
New +$31.5M 0.04% 419
2025
Q1
Sell
-50,000
Closed -$13.8M 2677
2024
Q4
$13.8M Buy
+50,000
New +$15.9M 0.02% 680
2024
Q2
Sell
-144,000
Closed -$49.9M 2592
2024
Q1
$49.9M Sell
144,000
-14,700
-9% -$4.84M 0.08% 255
2023
Q4
$47.5M Buy
+158,700
New +$46.4M 0.08% 246

Other funds holding CI

Marshall Wace's CI Position: Q1 2026 in Review

Marshall Wace increased its Cigna (CI) stake by 6,197% in Q1 2026, buying an estimated $15.6M and bringing the position to 57,180 shares worth $15.3M. The position accounts for 0.02% of the portfolio, ranked #794.

Marshall Wace first reported a position in CI in Q2 2014 and has held it in 41 quarters since. The position peaked at $433M in Q3 2022. 1,654 funds tracked by Wall St. Rank hold CI as of Q1 2026.

  • Marshall Wace held 57,180 shares of Cigna worth $15.3M as of Q1 2026.
  • Marshall Wace bought 56,272 Cigna shares in Q1 2026, an estimated $15.6M.
  • Cigna made up 0.02% of Marshall Wace's portfolio in Q1 2026, its #794 holding.
  • Marshall Wace first reported a position in Cigna in Q2 2014 and has held it in 41 quarters since.
  • Marshall Wace's Cigna position peaked at $433M in Q3 2022.
  • 1,654 funds tracked by Wall St. Rank held Cigna as of Q1 2026.

Based on Marshall Wace's 13F filing for Q1 2026, filed 15 May 2026.